NEWS COMMENTARY

Livongo Health and Health Catalyst join a growing list of digital health IPOs this year

Published:
July 30, 2019
Coverage:
Digital Transformation More...
Activities:
Markets More...
by Nardev Ramanathan
Very important

Both companies went public on the same day, with a strong debut. Change Healthcare and Phreesia, two other digital health companies, also went public recently. A shared feature among these companies is that they all offer solutions that support an emerging trend of a patient-centric, decentralized care model. The exuberant market response is a strong confidence booster for the digital health space, but clients should still perform their own due diligence before investing. Companies like Theranos are clear examples to avoid, but clients should also look at factors beyond the value proposition and validation of the core technology. We've seen how uBiome, despite a sound technology, raised concerns over its unscrupulous corporate practices.

For the original news article, click here .


Further Reading

uBiome to expand into microbiome-based therapeutics with Series C funding

News Commentary | September 28, 2018

Microbiome analysis provider uBiome (Lux Take: Positive) raised $80 million in a Series C funding round led by OS Fund, with notable participation from 8VC, Dentsu Ventures, and Y Combinator. With the newly raised funding, the company hopes to expand further into microbiome‑based drug research and ... Not part of subscription

German Private Health Insurance Association (PKV) launches new €100 million fund to invest in digital health startups

News Commentary | September 12, 2019

It is expected that the participating private health insurance companies within PKV will provide a target volume of €100 million to support startups focusing on areas like preventative medicine and telehealth. While large multimillion‑dollar funds looking to invest in digital health startup is not ... Not part of subscription

Sanofi backs out from its digital diabetes and cardiovascular programs

News Commentary | December 17, 2019

This announcement effectively ends Sanofi's partnership with Onduo, a joint venture with Verily. Back in 2016, both Verily and Sanofi invested half a billion dollars in this ambitious program, with Sanofi execs touting this as an example of their commitment to digital health innovation. Onduo has ... Not part of subscription